Quick Answer
VOLITIONRX LTD reported Long-Term Debt of $5.82 million for fiscal year 2025.
VOLITIONRX LTD Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $5.82M | +47.2% |
| 2024 | $3.95M | +9.0% |
| 2023 | $3.62M | +30.4% |
| 2022 | $2.78M | +22.4% |
| 2021 | $2.27M | -12.9% |
| 2020 | $2.61M | +18.7% |
| 2019 | $2.20M | +10.6% |
| 2018 | $1.98M | +51.1% |
| 2017 | $1.31M | +203.9% |
| 2016 | $432.0K | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.57M | +45.0% | -3.6% |
| June 30, 2025 | $5.77M | +49.3% | +4.3% |
| March 31, 2025 | $5.53M | +64.0% | +40.0% |
| December 31, 2024 | $3.95M | +9.0% | +3.0% |
| September 30, 2024 | $3.84M | +84.0% | -0.7% |
| June 30, 2024 | $3.87M | +57.6% | +14.6% |
| March 31, 2024 | $3.37M | +32.3% | -7.0% |
| December 31, 2023 | $3.62M | +30.4% | +73.8% |
- VOLITIONRX LTD showed an increase of +47.2% in Long-Term Debt compared to the prior fiscal year.
- Over the 2016–2025 period, VOLITIONRX LTD’s long-term debt has grown by 1246.8% (from $432.0 thousand to $5.82 million).
- The most recent figure is from VOLITIONRX LTD’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: